BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Critical Outcome Technologies Inc. Announces the Issuance of Stock Options

  September 11, 2009

   · 

  1 min read
• BioForest

  Stem Cell Therapeutics Announces Dr. V. Wee Yong’s Presentation at the 25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis

  September 11, 2009

   · 

  3 min read
• BioMidwest

  Amedica Corporation Announces New Global Headquarters

  September 11, 2009

   · 

  1 min read
• Drug Development

  Genzyme Corporation’s Alemtuzumab for Multiple Sclerosis Shows Durable Treatment Benefit in Review of Four-Year Phase 2 Trial Data

  September 11, 2009

   · 

  7 min read
• Biotech Bay

  ProTrials Research, Inc. Named One of the Fastest-Growing Companies in the U.S. and a Top Women-Owned Business in Silicon Valley

  September 11, 2009

   · 

  1 min read
• Pharm Country

  Taro Pharmaceutical Industries Ltd. Announces Postponement of September 13, 2009 Shareholders Meeting

  September 11, 2009

   · 

  1 min read
• Policy

  Merck & Co., Inc.: Mistrial Declared in First Federal FOSAMAX(R) Trial

  September 11, 2009

   · 

  1 min read
• Pharm Country

  American Oriental Bioengineering, Inc. Launches New OTC Product to Treat Throat Inflammation

  September 11, 2009

   · 

  2 min read
• Policy

  Merz Pharmaceuticals, LLC’s Belotero(R) Balance PMA Filing Formally Accepted for Review by the FDA

  September 11, 2009

   · 

  1 min read
• Biotech Bay

  DURECT Corporation (JOBS) Announces Sale of 4,444,444 Shares of Common Stock, Raising Proceeds of $10 Million

  September 11, 2009

   · 

  2 min read